MYP_165850
Basic Information
Unnamed
Anticancer
Immunology Immunomodulation Immunogenic
Standard
11 amino acids
C54H86N14O17S
Standard
Sequence
FATPMEAELAR
Physicochemical Analysis
1235.41 Da
4.53
-1.23
-1.44
-0.1122
0.01
0.34
0.07
2.24
62.73
0.0909
0.00
0.00
The radar chart summarizes major physicochemical dimensions for quick comparison, while exact numerical values remain listed on the left.
Residue Composition
Amino Acid Composition
Chemical Descriptors
502.26
-3.77
17.0
17.0
38.0
86.0
2.0
10.0
Structural Visualization
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber in the current view mode. Use the buttons to zoom.
2D CHEMICAL STRUCTURE
Drag to move
Drag to move. Use the buttons to zoom.
Experimental Records
RECORD: Rec_0057166 VERIFIED: YES
Provenance & Taxonomy
Homo sapiens [Animal]
Tumor-associated antigen
9606
Structure & Mods
linear peptide [Linear]
mixed L/D amino-acid peptide [Mixed]
Bio-Activity Profile
Anticancer Immunogenic
non-small cell lung cancer; HLA-C*12:02
ELISPOT
RECORD: Rec_0281400 VERIFIED: YES
Provenance & Taxonomy
Homo sapiens [Animal]
Tumor-associated antigen
9606
Structure & Mods
linear peptide [Linear]
mixed L/D amino-acid peptide [Mixed]
Bio-Activity Profile
Anticancer Immunogenic
non-small cell lung cancer; HLA-C*12:02
Cytotoxicity
RECORD: Rec_0331868 VERIFIED: NO
Provenance & Taxonomy
Homo sapiens [Animal]
Tumor-associated antigen
9606
Structure & Mods
linear peptide [Linear]
mixed L/D amino-acid peptide [Mixed]
Bio-Activity Profile
Anticancer
non-small cell lung cancer; HLA-C*12:02
16.7334 μM
Predicted HLA-I binding